A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days and potentially eliminating the need for invasive procedures.
\n
\nUnveiled at the European Society of Human Genetics conference, the test requires only 1ml of blood, making it minimally invasive compared to procedures like muscle biopsies, which often necessitate general anesthesia in young patients.<\/p>\n
While rare diseases are, as the name suggests, uncommon \u2014 there are over 7,000 rare diseases affecting an estimated 300 million people globally. Many of these people will remain undiagnosed for their entire lives due to inconclusive testing \u2014 others have to wait years or even decades to receive accurate results.<\/p>\n
By incorporating samples from both parents \u2014 a method known as trio analysis \u2014 this game-changing test can distinguish between carriers and affected parties with greater accuracy and speed.
\n\u201cThe ability to use so little blood from infants and to produce robust results with a rapid turnaround time has been revolutionary to families,\u201d co-author Dr Daniella Hock, a senior postdoctoral researcher at the University of Melbourne, Australia, said in a press release.<\/p>\n
Moreover, the use of familial samples for trio analysis greatly improves the differentiation between carrier and affected individuals with higher confidence, and that has exceeded our initial expectations. We believe that the use of this test in clinical practice will bring considerable benefits to patients, their families and to healthcare systems by reducing the diagnostic time. Beyond providing swift diagnoses, the test offers families access to appropriate treatments, prognoses and reproductive options to prevent the recurrence of disease in future pregnancies. \u201cNon-invasive agnostic approaches such as genome sequencing and protein analysis will allow us to reach a diagnosis more rapidly in the future,\u201d Professor Alexandre Reymond, chair of the conference, said. For instance, NHS England is launching a scheme to screen 100,000 newborns for over 200 genetic conditions through whole genome sequencing. The new test for rare genetic diseases is a groundbreaking development that promises to transform the diagnosis and treatment of these conditions. With its ability to provide rapid and accurate results, it has the potential to improve the lives of millions of people worldwide. As research continues to advance, we can expect to see even more innovative solutions for the diagnosis and treatment of genetic diseases.<\/p>\n New Test for Rare Genetic Diseases Introduction to the Test A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days and potentially eliminating the need for invasive procedures. Unveiled at the European Society of Human Genetics conference, the test requires only 1ml […]<\/p>\n","protected":false},"author":6,"featured_media":18163,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22],"tags":[],"class_list":{"0":"post-18162","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-wellness"},"jetpack_featured_media_url":"https:\/\/i1.wp.com\/nypost.com\/wp-content%2Fuploads%2Fsites%2F2%2F2025%2F05%2Fpicture-little-boy-blood-sample-105329857.jpg?quality%3D90%26strip%3Dall&w=1920&resize=1920,1280&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/18162"}],"collection":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/comments?post=18162"}],"version-history":[{"count":1,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/18162\/revisions"}],"predecessor-version":[{"id":18164,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/posts\/18162\/revisions\/18164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/media\/18163"}],"wp:attachment":[{"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/media?parent=18162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/categories?post=18162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/citystuff.com\/new-york\/wp-json\/wp\/v2\/tags?post=18162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nThe test requires only 1ml of blood, making it minimally invasive compared to other procedures. sushytska \u2013 stock.adobe.com<\/span><\/p>\nImpact on Families and Healthcare<\/h2>\n
\nFor healthcare systems, this single analysis could replace a battery of targeted tests, leading to reduced costs and earlier interventions.
\n\u201cThe ability to use so little blood from infants and to produce robust results with a rapid turnaround time has been revolutionary to families,\u201d co-author Dr Daniella Hock said. NDABCREATIVITY \u2013 stock.adobe.com<\/span><\/p>\nFuture of Genetic Disease Diagnosis<\/h2>\n
\n\u201cThey will also permit the solving of previously unsolvable cases, thus helping families worldwide.\u201d
\nThis advancement aligns with global efforts to enhance early detection of genetic conditions.<\/p>\nGlobal Efforts<\/h2>\n
\nAnd researchers at Columbia University have created a rapid test that accurately detects whether a fetus has extra or missing chromosomes \u2014 the test costs as little as $50 to run and the results are returned within hours.<\/p>\nConclusion<\/h2>\n
FAQs<\/h2>\n
\n
\nA: The new test is a blood test that can detect thousands of rare genetic diseases in babies and children, offering results in under three days.<\/li>\n
\nA: The test works by incorporating samples from both parents, using a method known as trio analysis, to distinguish between carriers and affected parties with greater accuracy and speed.<\/li>\n
\nA: The test provides swift diagnoses, offers families access to appropriate treatments, prognoses, and reproductive options, and can replace a battery of targeted tests, leading to reduced costs and earlier interventions.<\/li>\n
\nA: Yes, the test requires only 1ml of blood, making it minimally invasive compared to procedures like muscle biopsies.<\/li>\n
\nA: The test aligns with global efforts to enhance early detection of genetic conditions, such as NHS England’s scheme to screen 100,000 newborns for over 200 genetic conditions through whole genome sequencing.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"